Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.

Priddy FH, Lewis DJM, Gelderblom HC, Hassanin H, Streatfield C, LaBranche C, Hare J, Cox JH, Dally L, Bendel D, Montefiori D, Sayeed E, Ackland J, Gilmour J, Schnepp BC, Wright JF, Johnson P.

Lancet HIV. 2019 Apr;6(4):e230-e239. doi: 10.1016/S2352-3018(19)30003-7. Epub 2019 Mar 15. Erratum in: Lancet HIV. 2019 Apr 3;:.

2.

Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.

Schnepp BC, Chulay JD, Ye GJ, Flotte TR, Trapnell BC, Johnson PR.

Hum Gene Ther. 2016 Jan;27(1):32-42. doi: 10.1089/hum.2015.136.

3.

Vector-Mediated In Vivo Antibody Expression.

Schnepp BC, Johnson PR.

Microbiol Spectr. 2014 Aug;2(4):AID-0016-2014. doi: 10.1128/microbiolspec.AID-0016-2014. Review.

PMID:
26104192
4.

Vector-mediated antibody gene transfer for infectious diseases.

Schnepp BC, Johnson PR.

Adv Exp Med Biol. 2015;848:149-67. doi: 10.1007/978-1-4939-2432-5_8. Review.

PMID:
25757620
5.

Adeno-associated virus delivery of broadly neutralizing antibodies.

Schnepp BC, Johnson PR.

Curr Opin HIV AIDS. 2014 May;9(3):250-6. doi: 10.1097/COH.0000000000000056. Review.

6.

Prevalence of human bocavirus in human tonsils and adenoids.

Clément N, Battaglioli G, Jensen RL, Schnepp BC, Johnson PR, St George K, Linden RM.

Emerg Infect Dis. 2009 Jul;15(7):1149-50. doi: 10.3201/eid1507.090102. No abstract available.

7.

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.

Johnson PR, Schnepp BC, Zhang J, Connell MJ, Greene SM, Yuste E, Desrosiers RC, Clark KR.

Nat Med. 2009 Aug;15(8):901-6. doi: 10.1038/nm.1967. Epub 2009 May 17.

8.

Infectious molecular clones of adeno-associated virus isolated directly from human tissues.

Schnepp BC, Jensen RL, Clark KR, Johnson PR.

J Virol. 2009 Feb;83(3):1456-64. doi: 10.1128/JVI.01686-08. Epub 2008 Nov 19.

9.

Characterization of adeno-associated virus genomes isolated from human tissues.

Schnepp BC, Jensen RL, Chen CL, Johnson PR, Clark KR.

J Virol. 2005 Dec;79(23):14793-803.

10.

Molecular characterization of adeno-associated viruses infecting children.

Chen CL, Jensen RL, Schnepp BC, Connell MJ, Shell R, Sferra TJ, Bartlett JS, Clark KR, Johnson PR.

J Virol. 2005 Dec;79(23):14781-92.

11.

Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Johnson PR, Schnepp BC, Connell MJ, Rohne D, Robinson S, Krivulka GR, Lord CI, Zinn R, Montefiori DC, Letvin NL, Clark KR.

J Virol. 2005 Jan;79(2):955-65.

12.

Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Schnepp BC, Clark KR, Klemanski DL, Pacak CA, Johnson PR.

J Virol. 2003 Mar;77(6):3495-504.

Supplemental Content

Loading ...
Support Center